You are here

Home » Content

DİYABETİK VE BENFLUOREKS-C VİTAMİNİ UYGULAMALI SIÇAN DERMİSİNDEKİ ELASTİK LİF VE FİBROBLAST DEĞİŞİMLERİNİN MİKROSKOBİK İNCELENMESİ

A MICROSCOPIC STUDY OF THE CHANGES IN ELASTIC FIBRES AND FIBROBLASTS IN DERMIS OF DIABETIC AND BENFLUOREX-VITAMIN C TREATED RATS

Journal Name:

  • Süleyman Demirel Üniversitesi Fen Dergisi

Publication Year:

  • 2009

Key Words:

Keywords (Original Language):

Author NameUniversity of AuthorFaculty of Author
Abstract (2. Language): 
This study analyses changes in elastic fibres and fibroblasts in dermis of diabeti c and benfluorex-vitamin C treated diabetic rats. Light and electron microscopy examinations revealed thickening of dermis and elastic fibres, pyknotic nucleus and swelling of endoplasmic reticulum in fibroblasts in streptozotocin diabetic rats. Among Benfluorex-C treated group, no degeneration of elastic fibres and thickening of dermis were determined. Moreover, active fibroblasts were observed in the treated group. These findings indicate the positive effect of Benfluorex and vitamin-C use in treatment of diabetic dermis.
Bookmark/Search this post with
Abstract (Original Language): 
Bu çalışma streptozotosin diyabetik ve benfluoreks-C vitamini tedavisi uygulanmış diyabetli derinin dermisindeki elastik lif ve fibroblastlarda meydana gelen değişimleri incelemektedir. Işık ve elektron mikroskobu incelemelerinde diyabet grubunda dermis kalınlaşması, elastik liflerde yoğunlaşmalar ve fibroblastlarda ise piknotik çekirdek ve dilate olmuş endoplazmik retikulumlar belirlenmiştir. Benfluoreks-C vitamini uygulamalı grupta ise diyabet grubunda gözlemlenen dejenerasyonlara rastlanmamış ve aktif fibroblastlar gözlenmiştir. Bu bulgular diyabetik deride benfluoreks-C vitamini uygulamasının elastik lifler ve fibroblast üzerine olumlu etkisi olduğunu göstermektedir.
FULL TEXT (PDF): 
PDF icon arastirmax-diyabetik-benfluoreks-c-vitamini-uygulamali-sican-dermisindeki-elastik-lif-fibroblast-degisimlerinin-mikroskobik-incelenmesi.pdf
  • 1
12-22
  • Turkish

REFERENCES

References: 

ADA (AMERICAN DIABETES ASSOCIATION). 2006. Diagnosis and classification of diabetes mellitus. Diabetes Care, 29 (1), 43-48.
BRINDLEY DN, AKESTER H, DERICK GP, IRVINE CD, PATMORE RD, SPENCER H, YULE-SMITH A, FINNERTY C, SAXTON J, MACDONALD I A, 1988. Effect of chronic administration of benfluorex to rats on the metabolism of corticosterone, glucose, triacylglycerol, glycerol and faty acid. Biochemical Pharmacology, 37(4); 695-705.
BOR MV, ELMALI ES, ALTAN N, 2000. Serum antiotensin converting enzyme
activity in streptozotocin-induced diabetic rats. Turkish Journal of Medical
Sciences, 30 (3), 311-313.
CERIELLO A, BORTOLOTTI N, CRESCENTINI A, MOTZ E, LIZZIO S, RUSSO A, EZSOL Z, TONUTTI L, TABOGA C, 1998. Antioxidant defences are reduced during the oral glucose tolerance test in normal and non-insulin-dependent diabetic subjects. European Journal of Clinical Investigation, 28 (4), 329- 333.
CONGET I, 2002. Diagnosis, classification and pathogenesis of diabetes mellitus. Revista Espanola De Cardiologia, 55 (5), 528-535.
CULLING CFA, ALLISON RT, BARR WT, 1985. Cellular Pathology Technique. Butterworth & Co. Ltd., London. pp. 175-176.
DAĞLI Ü, ŞENEL Z, YILMAZ N, YALÇIN S, 1992. Diabetik karyoatropi üzerine klinik ve histopatolojik çalışma. Turkish Journal of Dermatopathology, 1, 29¬34.
DURAN V, GAJINOV Z, VUCKOVIC N, MATOVIC L, MATIC M, IVCOV-SIMIC
M, POJACKI M, 2001. Skin disorder in diabetic patients and pathohistological diagnostics. Archive of Oncology, 19 (1), 129-130.
EISELEIN L, SCHWARTZ HJ, RUTLEDGE JC, 2004. The challenge of type I
diabetes mellitus. Institute for Laboratory Animal Research Journal, 45 (3), 231-236.
EKMEKTZOGLOU KA, ZOGRAFOS GC, 2006. A concomitant review of the effects of diabetes mellitus and hyperthyroidism in wound healing. World Journal of Gastroenterology, 12 (17), 2721-2729.
HANNA W, FRISEN D, BOMBARDIER C, GLADMAN D, HANNA A, 1987.
Pathologic features of diabetic thick skin. Journal of The American Academy Dermatology, 16 (3), 546-553.
HEIDARI Z, SAGHEB HM, RAFIGHDOOST H, MOEIN A, MUGAHI MN, MINAII B, 2003. A streological study of diabetic kidney following administration of different doses of streptozocin. Daru, 11 (3), 115-119.
S. M. SARI
KILIÇASLAN
, C. AYVALI, B. GÖNÜL, Ç. ÖZER
KOHL C, RAVEL D, GIRARD J, PEGORIER J, 2002. Effects of benfluorex on fatty
acid and glucose metabolism in isolated rat hepatocytes. From metabolic fluxes to gene expression. Diabetes, 51, 2363-2368.
LANGEVIN HM, CORNBROOKS CJ, TAATJES D, 2004. Fibroblasts form a body-
wide cellular network. Histochemistry and Cell Biology, 122 (1), 7-15.
MAHAJAN S, KORANNE RV, SHARMA SK, 2003. Cutaneous manifestation of
diabetes mellitus. Indian Journal of Dermatology, Vereneology and Leprology, 69 (2), 105-108.
MCLENNAN S, YUE DK, FISHER E, CAPOGRECO C, HEFFERNAN S, ROSS GR, TURTLE JR, 1988. Defiency of ascorbic acid in experimental diabetes. Relationships with collagen and polyol pathway abnormalities. Diabetes, 37 (3),
359-361.
MYTHILI MD, VYAS R, AKILA G, GUNASEKARAN S, 2004. Effect of
streptozotocin on the ultrastructure of rat pancreatic islet. Microscopy Research
and Technique, 63, 274-281. PAPADIMITRIOU JM, HENDERSON DW, SPAGNOLO DV, 1992. Diagnosti
Ultrastructure of Non-Neoplastic Diseases. Churchill Livingstone Longman
Group UK Limited, United Kingdom. pp.65. PEREZ MI, KOHN SR, 1994. Cutaneous manifestations of diabetes mellitus, Journal
of the American Academy of Dermatology, 30, 519-531.
ROMANO G, MORETTI G, DI BENEDETTO A, GIOFRE C, DI CESARE E, RUSSO G, CALIFANO L, CUCINATTO D, 1998. Skin lesion in diabetes mellitus; prevalence and clinical correlations. Diabetes Research Clinical Practise, 39,
101-106.
SERRADAS P, BLONDEL O, BAILBE D, PORTHA B, 1993. Benfluorex normalizes hyperglycemia and reverses hepatic insulin resistance in STZ-induced diabetic rats. Diabetes, 42, 564-570.
WEST IC, 2000. Radicals and oxidative stress in diabetes. Diabetic Medicine, 17, 171¬180.

Thank you for copying data from http://www.arastirmax.com